HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SACATM Examines Federal Five-Year Plan For Non-Animal Toxicity Research

This article was originally published in The Rose Sheet

Executive Summary

The Scientific Advisory Committee on Alternative Toxicological Methods considered a proposed federal research priority ranking for the development of non-animal-based approaches to toxicity testing at a Nov. 30 meeting in Research Triangle Park, N.C
Advertisement

Related Content

Federal Commitment To Reducing Animal Testing Called Into Question
Federal Commitment To Reducing Animal Testing Called Into Question
ICCVAM, NICEATM Request Info On Non-Animal Testing; June Deadlines Set
ICCVAM, NICEATM Request Info On Non-Animal Testing; June Deadlines Set
ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing
ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing
EU REACH, Seventh Amendment Issues Addressed By Lauder Exec
EU Path To Alternative Methods: Labeling Guidelines, “3Rs” Plan Issued
EU Path To Alternative Methods: Labeling Guidelines, “3Rs” Plan Issued
Advertisement
UsernamePublicRestriction

Register

RS014408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel